Navigation Links
Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
Date:3/28/2008

- Preclinical Data Indicates MSI-1436 Does Not Alter Rate of Dopamine

Uptake -

PLYMOUTH MEETING, Pa., March 28 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) announced that preclinical data was presented Thursday at the Chicago Chapter of the Society of Neuroscience by Mitchell F. Roitman, Ph.D., a Genaera collaborator and investigator with the University of Illinois at Chicago. The abstract titled "A novel anti-obesity drug MSI-1436 does not alter the rate of dopamine uptake via the dopamine transporter," demonstrates that MSI-1436 does not inhibit the dopamine transporter in vivo by directly measuring dopamine levels in the brain of rats after MSI-1436 administration.

Dopamine is a neurotransmitter found in the brain which can have affects on locomotor function and addictive behavior. Many drugs that reduce food intake and body weight affect the rate of dopamine reuptake by inhibiting the dopamine transporter (DAT), such as amphetamine and bupropion. Such compounds, which inhibit the dopamine transporter, are considered undesirable as weight- loss drugs since they affect locomotor behavior and may have high addictive potential. MSI-1436 is a protein tyrosine phosphatase 1B inhibitor (PTP-1B), which increases insulin sensitivity and reduces food intake in animals, and is currently in clinical development for anti-obesity and anti-diabetes therapy. Preliminary in vitro studies in cells suggested that MSI-1436 may interact with the dopamine transporter but in vivo behavioral tests in rats did not show DAT-inhibitory activity. Therefore, a definitive study to resolve this discrepancy was designed.

The effects of MSI-1436 on dopamine reuptake were investigated using in viv
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
3. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
6. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
7. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
8. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. CEL-SCI Corporation Releases Letter to Shareholders
11. Alfacell Corporation to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 Thync today launched the ... in minutes; feeling more calm or energized when you need ... sleek and simple wearable is placed on the head and ... The neurosignaling device is operated with an accompanying app to ... your energy level. "Our mission at Thync ...
(Date:6/2/2015)... A new report by the ... million people across 13 countries bring an end to ... GSF,s latest Progress Report details how its financial support ... over 20,500 communities become open-defecation free, improved toilets for ... access to hand-washing facilities. The Progress Report ...
(Date:6/2/2015)... Los investigadores clínicos ... meses en la supervivencia libre de progresión en ... metastático inoperable (mCRC) tratados  en primera línea con ...    Los beneficios de añadir las ... con la quimioterapia sistémica actual para el tratamiento ...
Breaking Medicine Technology:Thync Launches First Wearable to Shift Your State of Mind 2Thync Launches First Wearable to Shift Your State of Mind 3Thync Launches First Wearable to Shift Your State of Mind 4Global Sanitation Fund Reports Major Sanitation & Hygiene Advances for Seven Million People in 13 Countries 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 3Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 4Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 5Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 6Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 7Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 8
... 2011 eCardio Diagnostics ( www.ecardio.com ) announced today ... an exclusive ranking of the nation,s fastest-growing private companies. ... #912 overall and #65 in the Health segment this ... The list represents the most comprehensive look at ...
... 24, 2011 "Production of Propofol was stopped after the ... Eglet attorney for the plaintiffs. In a stunning turn in ... Robert Eglet told the jury that production of the sedative ... million verdict in the Chanin trial in May 2010. Teva ...
Cached Medicine Technology:Inc. Magazine Unveils Its Annual Exclusive List of America's Fastest-Growing Private Companies—the Inc. 500|5000 22nd Day of Testimony: Mainor Eglet Attorney Continues Questioning Teva Pharmaceuticals Vice President 2
(Date:6/2/2015)... of Monarch Landing in Naperville are going to run ... yoga, play volleyball, or participate in whatever their exercise ... Walk to End Alzheimer’s on September 20 in Naperville, ... to exercise for 60 days, sponsored by Life Care ... walk will raise awareness of Alzheimer’s disease among the ...
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling celebrity ... summer fashion cocktail dresses. The company carries more than ... be suitable for a wide variety of summer events ... and make high quality trendy special occasion dresses ... quality satin, chiffon and cotton. Their products feature a ...
(Date:6/2/2015)... 02, 2015 Mercy Health (formerly Catholic ... and Kentucky – has devoted the seventh of its ... skin cancer prevention. One in five Americans will get ... Health’s YouTube channel, a Mercy Health expert addresses these ... main causes of skin cancer? ,     What are ...
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 TranSlice: Reveal ... a new style. TranSlice: Reveal allows Final Cut Pro X ... growing lines to reveal their next screen. , TranSlice Reveal ... style. Final Cut Pro X users can now ... growing lines. , With every panel orientation and direction covered, ...
(Date:6/2/2015)... Consumer Reports, the world’s largest ... its commitment to help wipe out antibiotic-resistant bacteria ... antibiotics sicken about 2.25 million Americans each year ... Disease Control and Prevention. , The initiative kicks ... Tellado participating in the White House Forum on ...
Breaking Medicine News(10 mins):Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3Health News:Video provides helpful information about skin cancer prevention 2Health News:Announcing the release of TranSlice Reveal from Pixel Film Studios - Professional Split Screen Transitions for FCPX. 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3
... WASHINGTON, Oct. 28 Trust for America,s Health ... new ad campaign today entitled Health Care vs. Sick ... provides a once-in-a-lifetime chance to transform our health care system ... and wellness," said Jeff Levi, PhD, Executive Director of TFAH. ...
... experts say , WEDNESDAY, Oct. 28 (HealthDay News) -- Diet ... cutting the risk for the disease by more than a ... , About 11 percent of U.S. adults (24 million) have ... and sedentary lifestyle. In addition, 57 million overweight adults have ...
... given night, an estimated 43,000 people are homeless in Los Angeles, ... Homeless Report (HC09), released today by the Los ... Los Angeles, while still the highest in the nation, represents an ... data shows that a significant number of homeless in Los Angeles ...
... at risk, experts say , , WEDNESDAY, Oct. 28 ... urinary tract infections are commonly treated with preventive antibiotics, ... therapy may have at least a modest effect. ... the antibiotic combination of trimethoprim plus sulfamethoxazole (brand names ...
... ... , ... 2009 -- The Harvard Health Publications Division of Harvard Medical School has ... draws on the extensive knowledge of the experts at Harvard Medical School along with ...
... LPBP Inc. (the "Company") announces a correction to ... the per share dividend payable on the Class ... the Class B Non-Voting shares should have read ... shares of $0.0099 per share remains the same. ...
Cached Medicine News:Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 2Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 3Health News:Diet, Exercise Thwart Diabetes: Study 2Health News:Diet, Exercise Thwart Diabetes: Study 3Health News:New Census Reveals Decline in Greater Los Angeles Homelessness 2Health News:New Census Reveals Decline in Greater Los Angeles Homelessness 3Health News:New Census Reveals Decline in Greater Los Angeles Homelessness 4Health News:Preventive Antibiotics Help Some Kids Fend Off Urinary Infections 2Health News:Preventive Antibiotics Help Some Kids Fend Off Urinary Infections 3Health News:Harvard Health Publications Launches H1N1 Flu iPhone Application 2Health News:Harvard Health Publications Launches H1N1 Flu iPhone Application 3
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Pocket-sized instrument. All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheos...
Pocket-sized instrument with fiber optic illumination. Swivelling viewing window with 3X magnification....
All metal construction with fiber optic illumination. Large diameter viewing port, insufflation port, and swivelling airtight window....
Medicine Products: